Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
JS Pharma Oy
OY
Active
Y-tunnus 2987364-9
Savarinkatu 9, 84100
Ylivieska
Retail sale of medical and orthopaedic goods
·
NACE 4774
Est. 2019 · 7 years old
— employees
Share
Finland
/
Companies
/
Retail sale of medical and orthopaedic goods
/
JS Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
844
935
1 023
1 086
1 159
Staff expenses
−0
−0
−0
−4
−9
EBITDA
247
274
303
323
348
Depreciation & amort.
−28
−21
−16
−12
−49
EBIT
219
253
287
311
299
Net financials
−0
−0
0
1
1
Profit before tax
219
253
287
313
300
Tax
44
51
57
63
60
Net profit
175
202
230
250
240
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
479
632
821
1 017
1 171
Equity
422
590
772
961
1 124
Long-term debt
—
—
0
0
0
Short-term debt
57
42
49
56
47
Total debt
57
42
49
56
47
Financial ratios
5-year trend
EBITDA-margin
30.0%
This company
15.8%
Market median
+90% vs market
2021
2025
Soliditetsgrad
96.0%
This company
38.2%
Market median
+151% vs market
2021
2025
Egenkapitalforrentning
21.3%
This company
18.4%
Market median
+16% vs market
2021
2025
Nettoresultatgrad
20.7%
This company
8.1%
Market median
+156% vs market
2021
2025
Aktivomsætning
0.99×
This company
1.12×
Market median
+12% vs market
2021
2025
Gæld/egenkapital
0.04×
This company
0.62×
Market median
+94% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on JS Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
